PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Wang-Gillam, Andrea
TI  - MM-398 Plus 5-FU and LV Extend OS and PFS in mPAC
DP  - 2014 Nov 01
TA  - MD Conference Express
PG  - 10--11
VI  - 14
IP  - 22
4099  - http://mdc.sagepub.com/content/14/22/10.short
4100  - http://mdc.sagepub.com/content/14/22/10.full
AB  - The addition of MM-398 to 5-flurouracil (5-FU) and leucovorin (LV) extended overall survival and progression-free survival in patients with metastatic pancreatic adenocarcinoma who had previously received gemcitabine-based treatment when compared with 5-FU plus LV alone. This article presents data from the Study of MM-398 With or Without 5-Fluorouracil and Leucovorin, Versus 5-Fluorouracil and Leucovorin in Patients With Metastatic Pancreatic Cancer [NAPOLI 1; Von Hoff D et al. Ann Oncol. 2014 (abstr O-0003)].